Neonatal non-invasive respiratory support: Physiological implications

Pediatric Pulmonology

Volumn 47, Issue 9, 2012, Pages 837-847

  Shaffer, Thomas H ^a,b,c   Alapati, Deepthi ^a,b   Greenspan, Jay S ^a,b   Wolfson, Marla R ^c  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bubble CPAP; CPAP; high flow nasal cannula; NIMV; nitric oxide; oxygen therapy; surfactant therapy

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; HUMAN; LUNG FUNCTION; METHODOLOGY; NASOGASTRIC TUBE; NEONATAL NON INVASIVE RESPIRATORY SUPPORT; NON INVASIVE MECHANICAL VENTILATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; BRONCHODILATOR AGENTS; BRONCHOPULMONARY DYSPLASIA; CONTINUOUS POSITIVE AIRWAY PRESSURE; DRUG COMBINATIONS; FATTY ALCOHOLS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; NONINVASIVE VENTILATION; OXYGEN INHALATION THERAPY; PHOSPHATIDYLGLYCEROLS; PROTEINS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 84865087560     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22610     Document Type: Article

References (90)

1. Northway WH Jr, Rosan RC, Porter DY,. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
2. Philip AG,. Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics 1975; 55: 44-50.
3. Taghizadeh A, Reynolds EO,. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol 1976; 82: 241-264.
4. Gibson E,. Apnea. In:, Spitzer A, editor. Intensive care of the fetus and neonate. St. Louis: Mosby-Yearbook; 1996. pp 470-481.
5. Rigatto H,. A critical analysis of the development of peripheral and central respiratory chemosensitivity during the neonatal period. In:, von Euler C, Lagercrantz H, editors. Central nervous control mechanisms in breathing: periodic and irregular breathing in adults and in the perinatal periody. New York: Pergamon Press; 1979.
6. 2 during wakefulness and sleep in preterm infants. Early Hum Dev 1982; 7: 1-10.
7. Rigatto H,. Control of breathing in the fetus and newborn. In:, Spitzer A, editor. Intensive care of the fetus and neonate. St. Louis: Mosby-Yearbook; 1996. pp 458-469.
8. Harris TN,. Physiological principles. In:, Goldsmith JP, Karothers EH, editors. Assisted ventilation of the neonate. Philadelphia: WB Saunders; 1988. p 28.
9. Antunes MJ, Greenspan JS,. Pulmonary function testing. In:, Spitzer A, editor. Intensive care of the fetus and neonate. St. Louis: Mosby-Yearbook; 1996. pp 517-530.
10. Bhutani VK, Rubenstein D, Shaffer TH,. Pressure-induced deformation in immature airways. Pediatr Res 1981; 15: 829-832.
11. Bhutani VK, Ritchie WG, Shaffer TH,. Acquired tracheomegaly in very preterm neonates. Am J Dis Child 1986; 140: 449-452.
12. Penn RB, Wolfson MR, Shaffer TH,. Effect of tracheal smooth muscle tone on the collapsibility of extremely immature airways. J Appl Physiol 1988; 65: 863-869.
13. Panitch HB, Allen JL, Ryan JP, Wolfson MR, Shaffer TH,. A comparison of preterm and adult airway smooth muscle mechanics. J Appl Physiol 1989; 66: 1760-1765.
14. Deoras KS, Wolfson MR, Bhutani VK, Shaffer TH,. Structural changes in the trachea of preterm lambs induced by ventilation. Pediatr Res 1989; 26: 434-437.
15. Allen JL, Wolfson MR, McDowell K, Shaffer TH,. Thoracoabdominal asynchrony in infants with airflow obstruction. Am Rev Respir Dis 1990; 141: 337-342.
16. Fox WW, Schwartz JG, Shaffer TH,. Effects of endotracheal tube leaks on functional residual capacity determination in intubated neonates. Pediatr Res 1979; 13: 60-64.
17. Gerhardt T, Hehre D, Bancalari E, Watson H,. A simple method for measuring functional residual capacity by N2 washout in small animals and newborn infants. Pediatr Res 1985; 19: 1165-1169.
18. Morgan WJ, Geller DE, Tepper RS, Taussig LM,. Partial expiratory flow-volume curves in infants and young children. Pediatr Pulmonol 1988; 5: 232-243.
19. Noher RH, Morrow PE,. Pulmonary surfactant: a surface chemistry viewpoint. Ann Biomed Eng 1975; 3: 119-159.
20. Notter RH, Shapiro DL,. Lung surfactant in an era of surfactant replacement. Pediatrics 1981; 68: 781-789.
21. Notter RH, Finkelstein JN,. Pulmonary surfactant: an interdisciplinary approach. J Appl Physiol 1984; 57: 1613-1624.
22. Raju TN, Vidyasagar D, Bhat R, Sobel D, McCulloch KM, Anderson M, Maeta H, Levy PS, Furner S,. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet 1987; 1: 651-656.
23. Jobe A, Ikegami M, Glatz T, Yoshida Y, Diakomanolis E, Padbury J,. Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest 1981; 67: 370-375.
24. Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996; 97: 1-6.
25. Tecklin J, editor. Cardiopulmonary physical therapy. St. Louis: Mosby; 1990. 585 p.
26. McPherson AR, Hittner HM, Kretzer FL,. 1986. Retinopathy of prematurity. Toronto: BC Decker; 237 p.
27. Lucey JF, Dangman B,. A reexamination of the role of oxygen in retrolental fibroplasia. Pediatrics 1984; 73: 82-96.
28. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol 1988; 106: 471-479.
29. Zhu Y, Chidekel A, Shaffer TH,. Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses. Crit Care Res Pract 2010; 2010: 8.
30. Johnson LH, Quinn GE, Abbasi S,. Vitamin E and ROP-the continuing challenge. In:, Klaus MH, Fanaroff AA, editors. Yearbook of neonatal-perinatal medicine. St. Louis: Mosby-Yearbook; 1993. pp xv-xxiv.
31. Graziani LJ, Spitzer AR, Mitchell DG, Merton DA, Stanley C, Robinson N, McKee L,. Mechanical ventilation in preterm infants: neurosonographic and developmental studies. Pediatrics 1992; 90: 515-522.
32. 2 during continuous positive airway pressure (CPAP) administration: reduced oxidative stress. Pediatr Res 2003; 53: 355A.
33. Wolfson MR, Bhutani VK, Bowen FW, Shaffer TH,. HeO2 breathing: reduction in respiratory work in bronchopulmonary dysplasia (BPD). Pediatr Res 1983; 17: 394.
34. Nawab US, Touch SM, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR,. Heliox attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol 2005; 40: 524-532.
35. Miller TL, Singhaus CJ, Sherman TI, Greenspan JS, Shaffer TH,. Physiologic implications of helium as a carrier gas for inhaled nitric oxide in a neonatal model of Bethanecol-induced bronchoconstriction. Pediatr Crit Care Med 2006; 7: 159-164.
36. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK,. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333-1340.
37. Saunders RA, Milner AD, Hopkin IE,. The effects of continuous positive airway pressure on lung mechanics and lung volumes in the neonate. Biol Neonate 1976; 29: 178-186.
38. Chernick V,. Hyaline-membrane disease: therapy with constant lung-distending pressure. N Engl J Med 1973; 289: 302-304.
39. DeLemos RA, McLaughlin GW, Robison EJ, Schulz J, Kirby RR,. Continuous positive airway pressure as an adjunct to mechanical ventilation in the newborn with respiratory distress syndrome. Anesth Analg 1973; 52: 328-332.
40. Herman S, Reynolds EO,. Methods for improving oxygenation in infants mechanically ventilated for severe hyaline membrane disease. Arch Dis Child 1973; 48: 612-617.
41. Goldberg RN, Abdenour GE,. Air leak syndromes. In:, Spitzer A, editor. Intensive care of the fetus and neonate. St. Louis: Mosby-Yearbook; 1996. pp 629-640.
42. Shaffer TH, Delivoria-Papadopoulos M,. Alterations in pulmonary function of premature lambs due to positive end-expiratory pressure. Respiration 1978; 36: 183-188.
43. Shaffer TH, Koen PA, Moskowitz GD, Ferguson JD, Delivoria-Papadopoulos M,. Positive end expiratory pressure: effects on lung mechanics of premature lambs. Biol Neonate 1978; 34: 1-10.
44. Hobelmann CF Jr, Smith DE, Virgilio RW, Peters RM,. Mechanics of ventilation with positive end-expiratory pressure. Ann Thorac Surg 1977; 24: 68-76.
45. Sturgeon CL Jr, Douglas ME, Downs JB, Dannemiller FJ,. PEEP and CPAP: cardiopulmonary effects during spontaneous ventilation. Anesth Analg 1977; 56: 633-641.
46. Martin RJ, Nearman HS, Katona PG, Klaus MH,. The effect of a low continuous positive airway pressure on the reflex control of respiration in the preterm infant. J Pediatr 1977; 90: 976-981.
47. Miller MJ, Carlo WA, Martin RJ,. Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr 1985; 106: 91-94.
48. Frost EA,. Effects of positive end-expiratory pressure on intracranial pressure and compliance in brain-injured patients. J Neurosurg 1977; 47: 195-200.
49. Järnberg PO, de Villota ED, Eklund J, Granberg PO,. Effects of positive end-expiratory pressure on renal function. Acta Anaesthesiol Scand 1978; 22: 508-514.
50. Murdaugh HV Jr, Sieker HO, Manfredi F,. Effect of altered intrathoracic pressure on renal hemodynamics, electrolyte excretion and water clearance. J Clin Invest 1959; 38: 834-842.
51. Hemmer M, Viquerat CE, Suter PM, Vallotton MB,. Urinary antidiuretic hormone excretion during mechanical ventilation and weaning in man. Anesthesiology 1980; 52: 395-400.
52. Hall SV, Johnson EE, Hedley-Whyte J,. Renal hemodynamics and function with continuous positive-pressure ventilation in dogs. Anesthesiology 1974; 41: 452-461.
53. Annat G, Viale JP, Bui Xuan B, Hadj Aissa O, Benzoni D, Vincent M, Gharib C, Motin J,. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADP, and prostaglandins. Anesthesiology 1983; 58: 136-141.
54. Bark H, Le Roith D, Nyska M, Glick SM,. Elevations in plasma ADH levels during PEEP ventilation in the dog: mechanisms involved. Am J Physiol 1980; 239: E474-E481.
55. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708.
56. Pillow JJ, Hillman N, Moss TJ, Polglase G, Bold G, Beaumont C, Ikegami M, Jobe AH,. Bubble continuous positive airway pressure enhances lung volume and gas exchange in preterm lambs. Am J Respir Crit Care Med 2007; 176: 63-69.
57. Blackson T, Sherman TI, Touch SM, Cox T, Shaffer TH,. Bubble continuous positive airway pressure (BCPAP) does not augment ventilation. Pediatr Res 2003; 53: 360A.
58. Sturtz WJ, Touch SM, Locke RG, Greenspan JS, Shaffer TH,. Assessment of neonatal ventilation during high-frequency oscillatory ventilation. Pediatr Crit Care Med 2008; 9: 101-104.
59. Diblasi RM, Zignego JC, Tang DM, Hildebrandt J, Smith CV, Hansen TN, Richardson CP,. Noninvasive respiratory support of juvenile rabbits by high-amplitude bubble continuous positive airway pressure. Pediatr Res 2010; 67: 624-629.
60. Barrington KJ, Bull D, Finer NN,. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics 2001; 107: 638-641.
61. Friedlich P, Lecart C, Posen R, Ramicone E, Chan L, Ramanathan R,. A randomized trial of nasopharyngeal-synchronized intermittent mandatory ventilation versus nasopharyngeal continuous positive airway pressure in very low birth weight infants after extubation. J Perinatol 1999; 19: 413-418.
62. Khalaf MN, Brodsky N, Hurley J, Bhandari V,. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics 2001; 108: 13-17.
63. Moretti C, Giannini L, Fassi C, Gizzi C, Papoff P, Colarizi P,. Nasal flow-synchronized intermittent positive pressure ventilation to facilitate weaning in very low-birthweight infants: unmasked randomized controlled trial. Pediatr Int 2008; 50: 85-91.
64. Lin CH, Wang ST, Lin YJ, Yeh TF,. Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity. Pediatr Pulmonol 1998; 26: 349-353.
65. Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvador A, Ehrenkranz RA, Brodsky NL,. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol 2007; 27: 697-703.
66. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D,. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled prospective study. J Pediatr 2007; 150: 521-526.
67. Owen LS, Morley CJ, Dawson JA, Davis PG,. Effects of non-synchronised nasal intermittent positive pressure ventilation on spontaneous breathing in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011; 96: F422-F428.
68. Chang HY, Claure N, D'Ugard C, Torres J, Nwajei P, Bancalari E,. Effects of synchronization during nasal ventilation in clinically stable preterm infants. Pediatr Res 2011; 69: 84-89.
69. Aghai ZH, Saslow JG, Nakhla T, Milcarek B, Hart J, Lawrysh-Plunkett R, Stahl G, Habib RH, Pyon KH,. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP). Pediatr Pulmonol 2006; 41: 875-881.
70. Beck J, Reilly M, Grasselli G, Mirabella L, Slutsky AS, Dunn M, Sinderby C,. Patient-ventilator interaction during neutrally adjusted ventilator assist in low birth weight infants. Pediatr Res 2009; 65: 663-668.
71. Reyburn B, Li M, Metcalfe DB, Kroll NJ, Alvord J, Wint A, Dahl MJ, Sun J, Dong L, Wang ZM, et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med 2008; 178: 407-418.
72. Jorch G, Hartl H, Roth B, Kribs A, Gortner L, Schaible T, Hennecke KH, Poets C,. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol 1997; 24: 222-224.
73. Berggren E, Liljedahl M, Winbladh B, Andreasson B, Curstedt T, Robertson B, Schollin J,. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000; 89: 460-464.
74. Arroe M, Pedersen-Bjergaard L, Albertsen P, Bode S, Greisen G, Jonsbo F, Lundstrom K, Struck J, Westergaard M, Peitersen B,. Inhalation of aerosolized surfactant (ExosurfÂ) to neonates treated with nasal continuous positive airway pressure. Prenat Neonat Med 1998; 3: 346-352.
75. Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Segal R,. An open label, pilot study of Aerosurf combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv 2010; 23: 303-309.
76. Wolfson MR, Jichuan W, Hubert TL, Gregory T, Mazela J, Clayton R, Shaffer TH,. Aerosolized KL4 surfactant dose-response in the spontaneously breathing CPAP-supported preterm lamb. Denver, CO: American Pediatric Society/Society for Pediatric Research; 2011.
77. Mazela J, Polin RA,. Aerosol delivery to ventilated newborn infants: historical challenges and new directions. Eur J Pediatr 2011; 170: 433-444.
78. Mazela J, Merritt TA, Finer NN,. Aerosolized surfactants. Curr Opin Pediatr 2007; 19: 155-162.
79. Kopelman AE, Holbert D,. Use of oxygen cannulas in extremely low birthweight infants is associated with mucosal trauma and bleeding, and possibly with coagulase-negative staphylococcal sepsis. J Perinatol 2003; 23: 94-97.
80. Kopelman AE,. Airway obstruction in two extremely low birthweight infants treated with oxygen cannulas. J Perinatol 2003; 23: 164-165.
81. Greenspan JS, Wolfson MR, Shaffer TH,. Airway responsiveness to low inspired gas temperature in preterm neonates. J Pediatr 1991; 118: 443-445.
82. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS,. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993; 91: 135-138.
83. Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H,. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001; 107: 1081-1083.
84. Chang G, Cox CA, Shaffer TH,. Nasal cannula, CPAP, and high-flow nasal cannula: effect of flow on temperature, humidity, pressure, and resistance. Biomed Instrum Technol 2011; 45: 69-74.
85. Lampland AL, Plumm B, Meyers PA, Worwa CT, Mammel MC,. Observational study of humidified high-flow nasal cannula compared with nasal continuous positive airway pressure. J Pediatr 2009; 154: 177-182.
86. Frizzola M, Miller TL, Rodriguez ME, Zhu Y, Rojas J, Hesek A, Stump A, Shaffer TH, Dysart K,. High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol 2011; 46: 67-74.
87. Dysart K, Miller TL, Wolfson MR, Shaffer TH,. Research in high flow therapy: mechanisms of action. Respir Med 2009; 103: 1400-1405.
88. Kinsella JP, Neish SR, Shaffer E, Abman SH,. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819-820.
89. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH,. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123: 103-108.
90. Antunes MJ, Greenspan JS, Cullen JA, Holt WJ, Baumgart S, Spitzer AR,. Prognosis with preoperative pulmonary function and lung volume assessment in infants with congenital diaphragmatic hernia. Pediatrics 1995; 96: 1117-1122.